Pacific University School of Pharmacy, 222 SE 8th Avenue, Hillsboro, 97123, USA.
Idaho State Board of Pharmacy, 199 W Shoreline Lane, Suite 303, Boise, ID, 83702-9103, USA.
Res Social Adm Pharm. 2018 May;14(5):501-504. doi: 10.1016/j.sapharm.2017.10.002. Epub 2017 Oct 7.
Four states have created advanced practice pharmacist designations in state law: advanced practice pharmacist (California), clinical pharmacist practitioner (Montana and North Carolina), and pharmacist clinician (New Mexico). To attain an advanced pharmacist designation, states typically require a fee and set a minimum education requirement either through continuing pharmacy education (CPE) or through attainment of a national certification or completion of a residency. Once attained, pharmacists may practice with additional scope of practice authorities, namely the ability to order and interpret drug therapy-related tests, and initiate or adjust/modify medications under a collaborative practice agreement (CPA). Uptake of advanced practice pharmacist designations has been light (range: 0.35%-9.8%). The additional scope of practice authority is on par with, and in some instances more restrictive than, other states with fewer barriers to entry. As such, the excitement surrounding advanced pharmacist designations may be disproportionate to the actual scope of practice gains when compared to other existing state laws.
高级执业药师（加利福尼亚州）、临床药师从业者（蒙大拿州和北卡罗来纳州）和药师临床医生（新墨西哥州）。为了获得高级药师的指定，各州通常需要收费，并通过继续教育（CPE）或通过获得国家认证或完成住院医师培训来设定最低教育要求。一旦获得指定，药剂师可以在额外的实践范围内执业，即有权开出处方和解释与药物治疗相关的测试，并根据合作实践协议（CPA）启动或调整/修改药物。高级执业药师的指定的采用率一直很低（范围：0.35%-9.8%）。额外的执业范围与其他进入壁垒较少的州的范围相当，在某些情况下甚至更受限制。因此，与其他现有州法律相比，与实际执业范围相比，高级药师指定的兴奋可能不成比例。
